NCT03670992 is a clinical trial of duodenal-pancreatectomy in Renal Cell Carcinoma, sponsored by Azienda Policlinico Umberto I.

Who is sponsoring NCT03670992?

NCT03670992 is sponsored by Azienda Policlinico Umberto I.

What drugs are being tested in NCT03670992?

Interventions in NCT03670992: duodenal-pancreatectomy.

What condition does NCT03670992 study?

NCT03670992 studies Renal Cell Carcinoma, Metastases, Neoplasm.

Is NCT03670992 still recruiting?

NCT03670992 is currently completed. Last updated 14 September 2018.

Last reviewed 2018-09-14 · How we verify

NCT03670992

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Surgical Treatment of Pancreatic RCC Metastases

Completed Last updated 14 September 2018

What this trial tests

trial testing duodenal-pancreatectomy in Renal Cell Carcinoma in 26 participants. Completed in 10 January 2017.

Timeline

10 January 2016

Primary endpoint
10 January 2017

10 January 2017

Quick facts

Lead sponsor	Azienda Policlinico Umberto I
Status	Completed
Study type	OBSERVATIONAL
Enrollment	26
Start date	10 January 2016
Primary completion	10 January 2017
Estimated completion	10 January 2017
Sites	1 location across Italy

Drugs / interventions tested

duodenal-pancreatectomy

Conditions studied

Renal Cell Carcinoma — all drugs for Renal Cell Carcinoma →
Metastases, Neoplasm — all drugs for Metastases, Neoplasm →

Sponsor

Azienda Policlinico Umberto I

Who can join

Eligibility, any sex, with Renal Cell Carcinoma or Metastases, Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Data from 26 patients undergoing resection of Pancreatic Metastases and extra-Pancreatic Metastases from RCC were retrospectively analysed. Clinical data were collected from a digital database and QoL was assessed through patient's interview and Karnofsky performance scale.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Role of metastasectomy in the management of renal cell carcinoma.
Mikhail M, Chua KJ, Khizir L, Tabakin A, et al · · 2022 · cited 20× · PMID 35965871 · DOI 10.3389/fsurg.2022.943604
Surgical-only treatment of pancreatic and extra-pancreatic metastases from renal cell carcinoma - quality of life and survival analysis.
Brozzetti S, Bini S, De Lio N, Lombardo C, et al · · 2020 · cited 9× · PMID 32404091 · DOI 10.1186/s12893-020-00757-0

Verify or expand the search:

Other recruiting trials for Renal Cell Carcinoma

Currently open trials in the same condition.

NCT07397611 — Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC · Phase 2 · recruiting
NCT07195682 — A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) · Phase 1 · recruiting
NCT07285044 — The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr · Phase 2 · recruiting
NCT07227402 — A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6 · Phase 3 · recruiting
NCT07123090 — A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma · Phase 2 · recruiting

Other Azienda Policlinico Umberto I trials

Trials by the same sponsor.

NCT06752135 — Node Positive Cervical Cancer Treated by Neoadjuvant Chemotherapy Plus Radical Surgery: a Single Center Experience · terminated
NCT06770894 — DPP4-Inhibitors and Bone Metabolism in Diabetes · Phase 3 · completed
NCT03579485 — An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens, Including NUC-sparing Regimens, · unknown
NCT03875417 — Multidisciplinary Management of HCC in Elderly Patients · completed
NCT03866395 — Effects of Ivabradine on Residual Myocardial Ischemia After PCI · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03670992 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Policlinico Umberto I
Last refreshed: 14 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03670992.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing